Occupational exposures and chronic obstructive pulmonary disease : a hospital-based case-control study. by Govender, Nadira. & Govender, Nadira.
OCCUPATIONAL EXPOSURES and CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE: A hospital- 
based case- control study 
 
 
Submitted to:  
 
NELSON R. MANDELA SCHOOL OF MEDICINE 





Submitted in partial fulfilment of the academic requirements for the 
degree:   






Professor Rajen N Naidoo 
 
CO-SUPERVISOR 
Professor Umesh G. Lalloo 
 







I, Nadira Govender, declare that this  Masters  in Medicine (Occupational 
Medicine) dissertation is my own work and all primary and secondary sources 
have been appropriately acknowledged. This dissertation has not been submitted 
to any other institution as part of an academic qualification. 
 
This Dissertation is prepared in partial fulfilment of the requirement of the 
Masters in Medicine (Occupational Medicine)  degree at the School of Family and 
Public Health Medicine, Nelson R Mandela School of Medicine, University of 




Department of Occupational and Environmental Health, 
Nelson R Mandela School of Medicine 
University of KwaZulu Natal South Africa 
 










My acknowledgement and appreciation to the following people who provided 
support and advice in the preparation of this dissertation: 
 
• Professor RN Naidoo for his immense patience, encouragement, guidance 
and availability  during his supervision of my dissertation and for his 
assistance with the statistical analysis 
• Professor U Lalloo for guidance with aspects of the questionnaire 
• Mrs Tonya Esterhuizen for providing guidance with some aspects of the 
statistical analysis 
• Drs Saloshni Naidoo and Poovendrie Reddy for statistical input and support 
• Dr Amanda Ryan for review of the final document and  insightful comments 
and recommendations 
• Mrs S Moodley for proofreading the thesis 
• Funding support provided by the Department of Occupational and 
Environmental Health, Nelson R Mandela School of Medicine, UKZN 
• The patients that provided the material for the research 
• The hospitals (RK Khan, Greys and Inkosi Albert Luthuli) and staff of the 
Respiratory clinic in each of these hospitals that assisted with patient 
recruitment 
• Ms Letisha Hiralal for assistance with interviewing of patients as well as 
data capture 
 iv 
• Colleagues within the Department of Occupational and Environmental 
Health for their advice, support and administrative assistance 
• And finally, my sincere gratitude to my husband, Ben, and sons, Nikhyle 
and Kimeel, for their patience, love and support during the completion of 
this dissertation. 
 v 
ACRONYMS AND ABBREVIATIONS 
 
ATS  : American Thoracic Society 
BOLD  : Burden of Occupational Lung Disease 
CI  : Confidence interval 
COPD  : Chronic Obstructive Pulmonary Disease 
CGF  : Chemicals, gas or fumes 
ECRHS : European Community Respiratory Health Survey 
ERS  : European Respiratory Society 
FEV1  : Forced expiratory volume in one second 
FVC  : Forced vital capacity 
GOLD  : Global Initiative on Obstructive Lung Disease 
LFT  : Lung function test 
OR  : Odds ratio 
PAR  : Population Attributable Risk 
PLATINO : Latin American Project for the Investigation of Obstructive 
Lung Disease    
PR : Prevalence Ratio 
RR : Relative Risk 
TB : Tuberculosis 
VGDF : Vapours, gases, dusts or fumes 
WHO : World Health Organisation 
 







TABLE OF CONTENTS 
DECLARATION .....................................................................................................iii 
ACRONYMS AND ABBREVIATIONS............................................................... vi 
ABSTRACT ........................................................................................................... 10 
CHAPTER I............................................................................................................ 13 
INTRODUCTION AND LITERATURE REVIEW .......................................... 13 
introduction .................................................................................................... 13 
literature review ............................................................................................. 14 
Purpose of the Research ............................................................................. 34 
Specific Objectives ....................................................................................... 34 
CHAPTER II ......................................................................................................... 36 
METHODS ......................................................................................................... 36 
OVERVIEW.................................................................................................... 36 
Study Design and study population ........................................................... 36 
collection of interview data .......................................................................... 37 
collection of exposure data.......................................................................... 38 
SPIROMETRY............................................................................................... 39 
Statistical Analysis ........................................................................................ 40 
Ethics .............................................................................................................. 42 
CHAPTER III ......................................................................................................... 44 
RESULTS........................................................................................................... 44 
Demographic characteristics and smoking ............................................... 44 
Occupational History and Exposures ........................................................ 46 
respiratory symptoms and disease diagnosis REPORTED by 
participants................................................................................................................. 50 
Multivariable Logistic Regression Analyses ............................................. 51 
Lung function among cases ........................................................................ 53 
CHAPTER IV ......................................................................................................... 56 
DISCUSSION .................................................................................................... 56 
REFERENCES .................................................................................................. 64 
 vii 
APPENDICES........................................................................................................ 70 
APPENDIX A ..................................................................................................... 71 
ETHICS CLEARANCE CERTIFICATE............................................................ 71 
APPENDIX B ..................................................................................................... 72 
LETTER OF PERMISSION FROM DEPARTMENT OF HEALTH ................ 72 
APPENDIX C...................................................................................................... 73 
CONSENT TO PARTICIPATE IN A STUDY OF OCCUPATIONAL 


























LIST OF TABLES 
Table 1. GOLD classification of COPD based on post-bronchodilator FEV1 and 
FEV1/FVC <0.70............................................................................................................... 15 
Table 2. Population based Prevalence studies of chronic bronchitis/ COPD ......... 17 
Table 3. Estimated population prevalence of COPD according to GOLD stage .... 19 
Table 4. Demographic and smoking characteristics of cases and controls ............ 45 
Table 5. Smoking history by sex within each group of smokers ............................... 45 
Table 6. Reported medical conditions of controls........................................................ 46 
Table 7. Frequent job descriptions reported by cases and controls ......................... 47 
Table 8. Cases and controls employment by industry ................................................ 48 
Table 9. Occupational exposure profile of cases and controls.................................. 49 
Table 10. Occupational exposure by sex...................................................................... 49 
Table 11. Occupational exposures and duration among cases and controls ......... 50 
Table 12. Adjusted odds ratios for COPD..................................................................... 52 
Table 13. Lung function classification of cases as per the GOLD Staging system 53 
Table 14. Unadjusted lung function parameters .......................................................... 54 
Table 15. Adjusted effect of explanatory variables on FEV1 from different linear 







Chronic Obstructive Pulmonary Disease is projected to rank 5th among the leading 
causes of disease by the year 2020. Risk factors include smoking, indoor and 
outdoor air pollution, previous respiratory infections, genetics, as well as 
occupational exposures. 
Aim 
The aim of this study was to determine the contribution of occupational exposures 
to the burden of Chronic Obstructive Pulmonary Disease (COPD) among a sample 
of hospital based patients. 
Methods 
Cases (n=110) with specialist physician diagnosed COPD from the three public 
sector specialist respiratory clinics in KZN and controls (n=102) from other non-
respiratory chronic ailment specialist clinics at the same institutions were selected.  
An interviewer administered questionnaire and exposure history was obtained for 
each participant. In addition, a valid lung function test was obtained for each case. 
Data was analysed using STATA version 10. Multivariate regression models were 
developed to examine the relationship between COPD and occupational 
exposures while adjusting for age, sex, smoking and previous history of 
tuberculosis. The relationship of FEV1 and occupational exposures, adjusted for 
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age, height, previous history of tuberculosis and smoking history, was investigated 
among cases. 
Results 
Cases and controls were similar with respect to age and sex distribution. Cigarette 
smoking differed significantly between cases and controls with a larger proportion 
of cases having ceased to smoke compared to controls (72% vs 46%, p<0.01). A 
higher proportion of controls reported employment in administrative, managerial 
and quality control positions (21.3% vs 12.0%, 7.7% vs 2.6% and 5.4% vs 0.3% 
respectively). Employment in the construction and shoe manufacturing industries 
was reported more frequently by cases (10.3% vs 3.2% and 10.0% vs 4.9% 
respectively). Cases were more likely than controls to have been exposed to dust 
(72% vs 28%, p<0.001) or to chemicals, gas or fumes (74% vs 25.5%, p<0.001) 
and reported exposure durations 3-4 fold higher than that of controls (p<0.001). 
Dust and chemical, gas or fume exposure was associated with an increased odds  
of developing COPD. Exposure to dusts (OR 7.9, 95% CI 3.9-15.7, p<0.001), 
chemicals, gas or fumes (OR 6.4, 95% CI 3.2-12.8, p<0.001) were significantly 
associated with odds of developing COPD. In addition, previous history of 
tuberculosis, as well as smoking were  associated with an increased odds of 
COPD (OR 5.7, 95% CI 1.2-27.4 p<0.001 and OR 6.4, 95% CI 2.3-17.7, p<0.001). 
Discussion and Conclusion 
This is one of  the first hospital based case-control studies looking at occupational 
contribution to  COPD undertaken in South Africa. In this sample of participants, 
strong associations were observed between self-reported occupational exposures 
to dust, and chemicals, gas or fumes, and physician’s diagnosis of COPD. The 
study also demonstrated a strong association between smoking and previous 
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history of tuberculosis, and risk of COPD.  The findings suggest that persons with 
known occupational exposures to respiratory irritants should be monitored to 
detect the onset of respiratory ill-health and that preventive strategies should 







INTRODUCTION AND LITERATURE REVIEW 
 
INTRODUCTION 
According to the World Bank and the World Health Organisation (WHO), Chronic 
Obstructive Pulmonary Disease (COPD) is projected to rank 5th among the 
leading causes of disease worldwide by 2020 [1]. The WHO's Global Burden of 
Disease and Risk Factors project in 2001 reported that COPD is the 5th leading 
cause of death in developed countries and the 6th leading cause of death in 
developing countries [1]. 
 
As the classical mineral dust induced pneumoconiosis decreases in frequency 
because of the control of exposure, obstructive airways disease has emerged as 
the most prevalent category of occupational respiratory disorder in industrialized 
countries. [2]. The prevalence of COPD is increasing worldwide. Risk factors are 
numerous and include smoking (an important universal risk factor), previous 
respiratory infections, indoor and outdoor air pollution as well as occupational 
exposures. There is increasing evidence that environmental factors (to which men 
and women are exposed at work) other than cigarette smoking also play a role [3]. 
 
As COPD is a common disease in the general population, even a small increase in 
the prevalence due to occupational exposure would have a major public health 
impact and should be preventable [2]. Assessing the occupational component of  
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COPD can better inform prevention strategies designed to reduce the morbidity 




DEFINITION OF COPD 
Measurement of COPD in epidemiological studies has not been simple as no 
agreement existed regarding the definition of COPD until the Global Initiative on 
Obstructive Lung Disease (GOLD) classification system was published  in 2001.  
Position papers on COPD by the The American Thoracic Society (ATS) and the 
European Respiratory Society (ERS) were published in 1995. The ATS defined 
COPD as a “disease state characterised by the presence of airflow obstruction 
due to chronic bronchitis or emphysema.” The definition by the ERS is based on 
progressive and irreversible decline of maximum expiratory flow [4]. The current 
definition of COPD as established by GOLD states that “COPD is a preventable 
and treatable disease with some significant extrapulmonary effects that may 
contribute to the severity in individual patients. Its pulmonary component is 
characterised by airflow limitation that is not fully reversible. The airflow limitation 
is usually both progressive and associated with an abnormal inflammatory 
response of the lungs to noxious particles or gases”[5]. This definition has also 
been adopted, in the main, by the American Thoracic Society (ATS) as well as the 
European Respiratory Society (ERS) [6].  
 
Airflow limitation in COPD as measured by spirometry, is a persistently low forced 
expiratory volume in one second (FEV1) and FEV1/ forced vital capacity (FVC) 
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ratio regardless of treatment. The current definition used by the above three 
organisations for airflow limitation is an FEV1/ FVC ratio of < 0.7. COPD is 
classified into 4 stages based on the level of impairment assessed by FEV1. The 
GOLD stages as well as the presence of chronic respiratory symptoms have been 
shown to be predictors of mortality [5]. GOLD classification of COPD by severity is 
based on post-bronchodilator FEV1 (Table 5) [5]. 
 
Table 1. GOLD classification of COPD based on post-bronchodilator FEV1 
and FEV1/FVC <0.70 
GOLD stage FEV1 as percent predicted 
l: Mild COPD ≥ 80% 
ll: Moderate COPD 50%≤FEV1<80% 
lll: Severe COPD 30%≤FEV1<50% 
lV: Very severe COPD <30% or <50% and chronic respiratory 
failure* 
(* Respiratory failure: arterial partial pressure of oxygen (Pao2) <8.0 kPa (60mm Hg) 
with or without arterial partial pressure of CO2 (PaCO2) > 6.7 kPa (50mm Hg) while 
breathing air at sea level)  
 
Historically, there have been many other components of the COPD classification. 
Chronic bronchitis and emphysema are two such independent components which 
may co-exist in one individual. Chronic bronchitis is defined as the “presence of a 
chronic productive cough for three months in each of two successive years, 
provided other causes of chronic cough have been ruled out” [6]. Emphysema, 
defined pathologically, is the “destruction of alveolar walls and permanent 
enlargement of the airspaces distal to the terminal bronchioles” [6]. As uncertainty 
 15 
 
remains around how most clinicians diagnose COPD,  the use of a standardized 
classification system such as that proposed by GOLD is advocated. 
 
PATHOPHYSIOLOGY AND RADIOLOGICAL FEATURES OF COPD 
Pathological changes of COPD include chronic inflammation as well as structural 
changes due to a repeated injury and repair process. These changes increase 
with disease severity. The inflammatory response in the lung, which is also 
exacerbated by oxidative stress, is considered to be an amplified normal response 
to the inhalation of noxious, chronic irritants. Chronic inflammation and structural 
changes leads to fibrosis and narrowing of peripheral airways, dynamic collapse of 
airways, as well as decreased gas transfer [5]. Radiological features if present, 
may include hyperinflation, bullae, as well as flattened hemidiaphragms.  
 
PREVALENCE OF COPD 
Global population estimates of COPD vary because of differences in definition, risk 
factors and diagnostic methodology. Although there have been several studies of 
chronic bronchitis in middle- and lower- income countries, the burden and 
determinants of COPD have not been well documented [7]. 
 
The lack of consistent methods in many countries, including South Africa, to 
adequately diagnose COPD has resulted in unreliable estimates of the prevalence 
of COPD worldwide [8]. Prior to the countrywide standardized prevalence studies, 
various population based studies were undertaken to assist in arriving at an 
estimate of COPD prevalence (Table 2). These include estimates from the United 
States of America (US) [6] and South Africa [7]. Limitations that were 
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acknowledged in the National Health Interview Survey [6], namely dependency on 
the proper recognition and diagnosis of COPD, as well as lack of validation of 
airway obstruction, were addressed, in part, by the Third National Health and 
Nutrition Examination Survey [6], whose population prevalence estimate (13.9%) 
was almost twice that of the preceeding survey. 
 
Table 2. Population based Prevalence studies of chronic bronchitis/ COPD 
Country Prevalence (%) Year of study 
US (National Health Interview Survey) [6] 5.9 2000 
US (Third National Health and Nutrition 
Examination Survey) [6] 
13.9 2003 







12 study sites [8] 10.1 2006 
 
As accurate estimates of COPD prevalence and risk factors are necessary to 
assist governments in health care planning for services that will be required, new 
initiatives, namely The Burden of Obstructive Lung Disease (BOLD) Initiative, in 
conjunction with The Latin American Project for the Investigation of Obstructive 
Lung Disease (PLATINO), developed standardized methods for estimating COPD 
prevalence. These methods, which can be used in countries at all stages of 
development,  were used to measure the worldwide prevalence of COPD [8]. The 
PLATINO study [9] launched in 2002 reported on the prevalence of COPD in 
adults aged 40 years or older in 5 major Latin American cities. Crude prevalence 
of COPD ranged from 7.8% (95% CI 5.9-9.7) in Mexico City to 19.7% (95% CI 
17.2-22.2) in Montevideo with males consistently demonstrating a higher 
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prevalence at each site. These estimates exceed the 4-10% prevalence reported 
in an international review of 32 studies, “Interpreting COPD Prevalence Estimates” 
by Halbert RJ et al in 2003.  [10].  The multicentre BOLD study (Table 3) 
undertaken in 2006 with 9425 participants aged 40 years or older estimated the 
worldwide prevalence of COPD across the 12 study sites. There was significant 
variation of GOLD Stage I (p< 0.0001) with a higher prevalence in males 
compared to females (11.8% vs 8.5% respectively. The overall prevalence 
reported for South Africa was 22.2% (±2.4) for males and 16.7% (±1.7) for 
females. This large difference compared to the other sites could be explained by 
several possible factors, foremost being the high prevalence of tuberculosis in 
South Africa as well as by the use of biomass fuels for heating and cooking among 
the rural and semi- urban population. In addition, as South Africa is still a 
developing country, a large proportion of the population is employed in traditionally 
dusty trades with exposure to occupational factors which may be implicated in the 
causation of COPD. The prevalence of GOLD stage ll or higher among 
participants from South Africa was higher than that among participants in other 
developing countries, namely China, Turkey, and the Philipines. Finally, smoking 
prevalence may be increasing and contributing to the increase in prevalence [8]. 
BOLD’s reported prevalence’s are  similar to the PLATINO study which used 
similar study methods, but higher than the meta-analysis of 32 population based 




Table 3. Estimated population prevalence of COPD according to GOLD stage 
 
Source: Buist A S , McBurnie M A, Vollmer W M, Gillespie S, Burney P, Mannino D 
M, et al. International variation in the prevalence of COPD (The BOLD Study): a 
population-based prevalence study .Lancet. 2007; 370:741-50. 
 
In view of the diagnostic or reporting biases that may occur with the different 
methodologies used in the estimation of COPD prevalence, the “best” method of 
determining population prevalence is in all probability by the ascertainment of lung 
function parameters. Spirometry, if performed appropriately, is minimally 
influenced by diagnostic methods and can produce a valid result. In addition, lung 
function is a rational, objective predictor of functional limitations and mortality. 
 
OCCUPATION AS A RISK FACTOR FOR COPD 
The significance of occupational exposures as a risk factor for COPD was 
observed as far back as the 1950s by Fletcher and other researchers. Fletcher, in 
1958 stated that  “men who work in dusty trades, especially coal miners, have a 
higher prevalence of symptoms and chronic bronchitis and emphysema” [11]. Until 
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the early 1980’s, the contributory role of only one aetiological agent, tobacco 
smoke, in the causation of COPD had been established beyond doubt [13]. 
Nonetheless, since 1984, a large body of evidence from worker cohort and 
community studies has supported occupational exposures as risk factors for the 
development of COPD [2, 4, 12, 13]. Furthermore, in less developed countries 
where occupational exposures could be greater due to less rigorous legislation 
and poor control measures, the contribution of work may be even more significant 
than in developed countries.  
 
There are inherent difficulties in establishing relationships between work-
exposures and COPD. They include the multifactorial aetiology of COPD with 
important host and non-occupational environmental determinants of risk. In 
addition, unlike other occupational dust related diseases eg the pneumoconiosis, 
patients with COPD secondary to occupational causes cannot be distinguished 
from individuals with COPD from another cause. Third, there is often dual 
exposure to cigarette smoke and workplace irritants. Fourthly, epidemiological 
studies are subject to the healthy worker effect and are often limited to the 
surviving “healthy” workforce thereby underestimating the effects of occupational 
exposures. Despite this, a notable body of evidence demonstrating that COPD is 
linked to specific occupational exposures has accumulated in the past two 
decades [2, 3, 11, 13-15]. Occupational exposures may affect the course of COPD 
in one or more different ways. They may cause COPD; modify the effect of 
tobacco smoke in causing COPD; produce greater disability by adding work 
related impairment to that caused by smoking; and may also accelerate the rate of 
lung function decline in persons with recognized COPD [16]. 
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Reviews of COPD and occupation 
Becklake conducted two landmark reviews which examined the role of occupation 
in the causation of chronic airflow limitation [3, 13]. The earlier review conducted in 
1985 looked at the relationship of chronic airflow limitation to work in dusty 
occupations. Selected longitudinal as well as cross-sectional studies published 
after 1973 comparing either dust-exposed with non-exposed workers, or lightly 
and heavily exposed workers were included in the review.   
 
In the 12 cross-sectional mining studies reviewed by Becklake, exposure 
assessments were done from job classification in all, and environmental 
measurements in 11 of the 12 studies. Personal exposure measurements were 
available for only 2 studies. Most of the cross-sectional studies revealed higher 
prevalence (46.3% and 71.7% for active and retired coal workers respectively) of 
bronchitis, defined as cough and sputum production for at least 3 months for two 
consecutive years [17], or cough and phlegm for at least 3 consecutive months of 
the year [18], and significant lower average ventilatory function in exposed workers 
compared to non-exposed or less exposed workers. A similar effect was also seen 
in smokers compared to non-smokers in most of the studies; however, 2 studies 
[19, 20] assessing the independent contribution of both smoking and dust 
exposure confirmed the independent effect of dust on COPD by comparing the 
data obtained from smoking and non-smoking matched pairs of dust exposed and 





Evidence for the contribution of occupational exposures to chronic airflow limitation 
was strengthened by results of several longitudinal studies published after 1973. 
These studies were undertaken in foundries, fertilizer factories, in construction, 
metallurgy, chemistry, flour milling, coal mining as well as in hard rock mining and 
had follow-up periods ranging from 5 to 12 years. All of the reviewed studies [21-
24], except one [25], showed significant annual generally equivalent smoking and 
occupational exposure related decline in ventilatory function. FEV1 declines 
ranged from 37 to 54 ml per year among non-smokers and from 48 to 56 ml per 
year among smokers. Among exposed and non or least exposed workers, FEV1 
declined between 50 to 54 ml and 42 to 53 ml per year respectively.  In addition, 
one of the follow-up studies [21] performed among 556 Parisian workers in 
metallurgy, chemistry and flour milling, demonstrated that reducing occupational 
exposure resulted in reduced risk and a lesser lung function decline over time. The 
annual rate of decline of FEV1 during 12 years was estimated for each participant 
from lung function measurements in 1960 and 1972 using a specific formula. 
Heavily exposed workers, who during the 12 year follow-up period (1960-1972) 
changed their jobs for non-medically related reasons had a diminished decline of 
FEV1 compared to other heavily exposed workers whose exposure remained 
unchanged; 42 ml/year versus 56 ml/year decline respectively.  This increased 
rate of lung function decline with change in occupation supports the causal role of 
these occupational exposures.  
 
A consistent feature of these studies, as pointed out by Becklake, was a 
comparable magnitude of effect for occupational exposures and moderate 
smoking. The excess annual loss of FEV1 ranged from 7-8 ml/year for dust after 
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accounting for age and smoking. The range for annual loss of FEV1 for smoking 
after accounting for age and dust exposure was similar at between 9-11 ml/ year. 
In this review, the criteria of consistency, strength, coherence and dose-response 
relationship required by Bradford-Hill to differentiate between association and 
causation have been met for coal mining as well as certain industrial exposures 
namely a variety of mineral dusts (silica, abrasives, iron), grain dusts, various 
gases as well as heat in the decline of lung function over time [3]. Apart from the 
mining and quarrying industries, the 1985 review also implicated fiberglass, saw 
dust, freon, auto exhaust, solvents as well as the tunneling and agricultural 
industries in the genesis of COPD [3].  
 
The benchmark review evaluating the role of occupational factors in relation to 
COPD is the 2003 ATS statement, “Occupational Contribution to the Burden of 
Airway Disease” [2]. In the main, the ATS statement provides a comprehensive 
review and analysis of appropriate population- based studies spanning several 
occupations and industries up until 1999 [11]. In addition, numerous reviews on 
COPD have followed the ATS statement that support the conclusions of the earlier 
reviews [26-29].  
 
Occupational exposures and decline in lung function 
In addition to numerous  studies [18, 19, 21, 23, 24, 30-38] in cohorts of industrial 
workers, and a limited number of case-control studies [39-41], several population 
or community based studies have demonstrated the effects of occupational 
exposures on respiratory symptoms and annual lung function decline. One of the 
major advantages of conducting community based studies is avoidance of the 
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healthy worker effect. Numerous community based studies [42-46] from Europe, 
China, New Zealand and the United States have demonstrated increased relative 
risks for respiratory symptoms, decline in lung function consistent with COPD, and 
excess annual declines in FEV1 due to work related exposures. In addition, the 
most current ATS review suggests that occupational exposures contribute an extra 
mean decline of 7-8ml/ year in FEV1 [2] in contrast to normal aging where the 
mean decline in FEV1 averages between 30-35 ml/year as demonstrated by 
cross-sectional studies. Over a 40 year work life, this seemingly low mean loss of 
7-8ml/ year would result in approximately 320ml loss in FEV1, with some 
individuals  experiencing either greater or lesser declines than estimated. 
Considering the mean 30-35ml/ year loss due to aging, the loss of 320ml 
contributed to by occupational exposures amounts  to a 10 year decline in FEV1 
over the lifetime of an individual.  
 
Krzyzanowski et al [45] observed an accelerated decline in FEV1 in men with self-
reported occupational exposure to dusts in a 13 year population-based 
prospective study in Cracow. The observed mean annual rate of FEV1 decline 
among men exposed to dust or chemicals at work was 61.1ml/year and 
61.3ml/year respectively after adjustment for age and height. In a 25 year follow-
up study [44] among 1591 Norwegian men, significant adjusted declines in 
FEV1(mean ± standard error) was noted for those exposed to metal fumes (56.8 
±1.9ml/ year) and sulphur dioxide (58.7±2.7 ml/year). In addition, subjects 
exposed to increasing numbers of workplace agents showed a progressive 
increase in the  mean annual decline of FEV1 adjusted for age, height and 
smoking status. The decline ranged from 52 ml/ year in subjects with no known 
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exposure to 61 ml/year in those individuals exposed to six or more occupational 
agents. In the Chinese study [42], FEV1 and F25-75  were significantly lower in 
those occupationally exposed compared to subjects without occupational 
exposure (among participants reporting not using coal stove heating). In 
individuals with early COPD, persistent work-related fume exposure as well as 
smoking, were reported to be significant independent predictors of post-
bronchodilator decrements in FEV1 in men [16]. Ongoing occupational fume 
exposure resulted in an adjusted 10ml/ year loss in FEV1.  
 
In contrast, a large population based study conducted on 13 253 participants aged 
20-44 years in 14 industrialised countries was unable to detect an association 
between occupational exposures and lung function decline. Probable explanations 
for this effect is a sample composed of young participants with limited duration of 
exposure among whom a decline in lung function was not evident at the time of 
the study, the healthy worker effect or newer, cleaner working environments [47].  
 
Respiratory symptoms and occupational expsures 
Significant associations between respiratory symptoms and occupational 
exposures were reported in population based studies [42, 43, 46]. Occupational 
exposure to biological dusts was associated with an increased risk (RR 1.9; 95% 






Industries, agents and job descriptions associated with an increased risk of 
COPD 
Recent reviews have identified specific jobs [48], occupational agents [14, 48] and 
industries [49, 50] as having an increased risk for the development of COPD. .  
 
Occupational exposures that have been studied include grain dust, wood dust, 
isocyanates, cadmium, coal and other mineral dusts, adhesives and welding 
fumes [13, 15, 20, 21, 24, 47, 51, 52]. Industries having a high risk for COPD 
include mining, construction and quarrying, textile, paper, agriculture, and 
foundries [3, 15, 17, 18, 30, 43, 44].  
 
Among textile, wood and food processing workers, an increased prevalence ratio 
(PR) of 2.2 (95% CI 0.5-9.2), 1.6 (95% CI 0.4-7.0) and 3.4 (95% CI 1.3-8.6) 
respectively for ex-smokers and  2.5 (95% CI 1.3-4.6), 2.1 (95% CI 1.1-4.1) and 
2.0 (95% CI 1.3-3.1) respectively for current smokers [47]. In another population 
based study, occupational exposure to biological dusts was reported to be 
associated with an increased odds (OR 2.7; 95% CI 1.4-5.2) of developing COPD 
[15] after adjustment for age, sex, smoking status and pack years.  
 
COPD in silica exposed workers 
Numerous epidemiological [18, 19, 31-33, 53] as well as pathological studies [54-
56] suggest that even in the absence of radiological signs of silicosis, silica dust 
exposure can lead to COPD. In most developed countries worldwide, the reduction 
in silica dust levels has resulted in a decline in morbidity and mortality from 
silicosis as well as silica dust associated tuberculosis. However,  in both 
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developed as well as less developed countries, COPD remains a health concern 
for exposed workers [13, 30, 44].  
 
A 2002 review [4] of studies (where radiological signs of silicosis were found or 
where results for radiological silicosis were not reported) looking at  the 
association between silica dust exposure and COPD, reported a decrease in FEV1 
and FEV1/ FVC with escalating respirable dust exposure. This decrement was 
observed in both smokers and non-smokers. The study populations in these 
studies included white South African (SA) gold miners, black gold miners from 
South African mines, Canadian hard rock miners as well as American 
molybdenum miners. 
 
A landmark study [33] examined the effects of silicosis and dust exposure on a 
working population of black miners on South African gold mines. FEV1 decreased 
by 200mls (p=0.006) and FEV1/FVC% by 3.6% (p= 0.0001) after 25 years of dust 
exposure, equating to an annual average loss of 8 mls FEV1. This was equivalent 
to the annual reduction of 6.9mls due to similar duration of smoking, adjusted for 
silicosis and dust exposure. Furthermore, silicosis was associated with a reduction 
of all measured lung function parameters and association persisted after 
adjustment for smoking, duration and intensity of underground exposure. Men with 
profusion 2/2 had a significant reduction of FEV1 of 320 mls compared to men with 
profusion 0/0 (p= 0.0001).  
 
 In a five year follow up study [32] of 2209 white South African gold miners, 
exposure, in a 50 year old male, to an average cumulative dust exposure of 
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14.4mg/m³, was associated with a loss of 236 ml of FEV1 (95% CI 135-338 ml) 
and 217 ml of FVC (95% CI 110-324 ml). As the average duration of underground 
dust exposure was 24 years, the loss equates to an adjusted mean decrement of 
9.8 ml/yr of FEV1 and 9.0 ml/yr of FVC due to dust exposure. In addition, the five 
year follow up revealed that miners had a steeper decline in FEV1 compared to 
similar aged non-miners in the general population.  
 
Norwegian tunnel workers were observed to have an increased adjusted OR of 2.5 
(95% CI 1.31-4.96) for development of COPD. In addition, for each year of 
exposure, the observed adjusted effected on FEV1 showed a statistically 
significant decline of 17 ml/ year in tunnel workers compared to 0.5 ml/year in 
outdoor construction workers [30]. A follow up study of 45 granite workers between 
1976 and 1988 reported a significant decline of 4.6% in FEV1, 5.4% in FEV1/ 
FVC, and 13.7% in FEF50 compared to the change in the population controls. 
These changes were larger in the retired granite workers compared to the younger 
active workers. A possible reason for this finding would be the relatively longer 
duration of exposure as well as the larger cumulative exposure of the retired 
workers. Furthermore, deposited dust in lung tissue would continue to effect 
changes in airway patency long after the worker is removed from exposure.  
 
ATTRIBUTABLE RISK DUE TO OCCUPATION 
ATS concluded in 2003 that the attributable fraction of COPD due to occupational 
exposures was 15-20% [2].  
 
A study by Hnizdo et al, 2002, investigated the association between COPD and 
employment by industry and occupation in the US population. The  overall 
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projected  PAR was 19% among smokers, and 31% among never smokers [57]. 
An additional US population based study reported the adjusted PAR for similarly 
exposed workers as in the Hnidzo study to be 20%. [58]. Excluding chronic 
bronchitis from the COPD definition increased the PAR to 31%.  
 
A recent  review lends support to the 2003 ATS Statement on the association 
between occupation and COPD [11]. For chronic bronchitis (defined by standard 
questionnaire criteria), the PAR (adjusted for smoking) ranged from 0-34% with a 
median value of 15%, similar to the ATS estimate.  Individual studies provided 
COPD PAR estimates of 20% [58], 11% [51], 27% [15], and 15% [57]. Additional 
estimates for the PAR  for occupational exposures among non-smokers ranged 
from 26% for COPD [57] to 53% for COPD mortality [51]. 
 
ADDITIONAL RISK FACTORS FOR COPD 
Although cigarette smoking and occupational exposures account for the major 
proportion of cases, other factors have been implicated in the development of 
COPD. They include genetic factors [12], indoor and outdoor air pollution [7, 29], 
previous respiratory infections including tuberculosis[4, 7, 59-62], age [29],  sex 
[29], and reactive airways [4, 13].  
 
Smoking 
Among the environmental factors concerned in the genesis of COPD, tobacco 
smoking is the most important [3]. Estimates from the WHO are that 73% of COPD 
in developed countries and 40% of COPD in less developed countries is related to 
smoking [29]. Not all smokers develop COPD. However in those that do, inter-
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individual variation exists, in respect to the severity of COPD as well as to reaction 
to interventions.  
 
A South African based study showed an increasing association of chronic 
bronchitis with increasing daily smoking among men with odds ratios of 1.5 (95% 
CI 08-3.0) and 2.5 (95% CI 1.2-5.3) among light  daily (1-14 per day) and heavy 
daily (15+ per day) smokers respectively. However, among women, the odds of 
developing chronic bronchitis were higher if you were a light daily smoker as 
compared to a heavy daily smoker; odds ratio of 2.3 (95% CI 1.4-3.8) versus 1.8 
(95% CI 0.6-5.8) [7]. A partial explanation for the lack of an exposure-response 
trend among women is the relatively low prevalence of smoking among women, 
especially heavy smoking [7]. 
 
A synergistic effect of silica dust and tobacco smoke on COPD mortality was 
reported in a South African study.[63]. Within the total sample, the odds of dying 
ranged from 1.0 (for the lowest dust level) to 5.3 (95% CI 1.8-15.9) for the highest 
level of dust exposure. The odds of COPD mortality ranged from 1.0 (for lowest 
smoking level) to 32.3 (95% CI 4.2-248.2) for the highest smoking level. The odds 
of dying for the highest smoking and dust exposure categories, was 21.0, much 
higher than that expected (8.8) if an additive effect was postulated.  
 
A recent case-control study [64] reported that exposure to cigarette smoking was 
associated with a seven-fold increase in the odds for developing  COPD (OR 6.7; 
95% CI 4.6-9.8) and occupational exposure to VGDF was responsible for a 
doubling of risk over baseline (OR 1.9; 95% CI 1.3-3.1). However, combined 
exposure to cigarettes and occupation was associated with a significantly 
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increased risk (OR 14.1; 95% CI 9.3-21.2). The excess probability analyses 
reported an additive effect for joint risk of both the exposures when COPD was 
defined as GOLD stage II or higher. Data from a more recent population- based 
study also reported that the risk estimate for chronic bronchitis in occupationally 
exposed smokers was greater than the sum of the OR of the individual exposures 
(3.9 versus 1.6 and 1.3) [65] 
 
Respiratory infections and tuberculosis 
Respiratory infections, including tuberculosis (TB), play an important role in both 
the development as well as progression of COPD. Even among individuals who 
successfully complete anti-tuberculosis treatment, permanent damage to the lungs 
is frequently observed with airways obstruction as a long-term complication of 
tuberculosis. Several studies [59, 61, 62, 66] have shown that silicosis, as well as 
exposure to silica dust, are risk factors for tuberculosis. Tuberculosis was found to 
be a strong predictor of chronic bronchitis in multivariate analysis in both males 
and females among 13 061 participants in a population based study. Among 
males the odds ratio was 4.9 (95% confidence interval of 2.6-9.1) and among 
females, 6.6, with a 95% confidence interval of 3.7-11.7 [7]. 
 
In a recent population based study [67] looking at the association between TB and 
COPD using post-bronchodilator spirometry, among those participants with a 
history of TB, prevalence of airways obstruction was 30.7% compared with 13.7% 
among subjects without a history of TB. For the entire sample, the adjusted OR 
(95% CI) for airways obstruction in those with TB was 2.3 (1.5-3.6). Following 
stratification by sex, and after adjustment for confounders, males and females with 
a history of TB were 3.9 (95% CI 1.9-8.3) and 1.7 (95% CI 0.95-3.1) times more 
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likely respectively, to present with airways obstruction than individuals without a 
history of TB.  
 
Genetic factors, indoor and outdoor air pollutants, age, gender and reactive 
airways 
Serine protease Alpha 1- antitrypsin (protease inhibitor phenotype Z [PI*Z]) 
deficiency is at present, the only genetic factor undoubtedly associated with COPD 
in humans. This phenotype affects only a small percentage of the general 
population and as such, is responsible for only a small proportion of the COPD 
cases. It is found in 1-3% of individuals with COPD [29]. Individuals with this 
deficiency have been shown to be at increased risk of chronic cough, lower FEV1 
as well as lower FEV1/FVC with exposure to gases, dusts, fumes and smoke, 
independent of personal cigarette smoking [12].  
 
Exposure to biomass fuels is an important global risk factor for the development of 
COPD. In less developed countries, the WHO estimates that as much as 35% of 
COPD cases can be attributable to exposure to indoor smoke from biomass fuels. 
A report on risk factors for COPD in females in China showed that never- smoking 
women in rural areas exposed to biomass fuel smoke had a two to three fold 
higher prevalence of COPD when compared to women from urban areas not 
exposed to biomass fuels [29]. A similar effect was shown by Ehrlich et al in 2004 
who reported an increased risk of developing chronic bronchitis among women 
with domestic exposure to smoky fuels. The authors reported an odds ratio of 2.0 
(95% CI 1.1-3.4) and this finding of increased risk was limited to female 
participants only [7]. Outdoor air pollutants contribute only a very small risk 
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towards the development of COPD.  The WHO estimates are 1% and 2% cases of 
COPD in developed and less developed countries respectively [29]. 
 
COPD prevalence increases with age, with concomitant decline in lung function 
after the fourth decade of life. On account of the changing demographics of the 
worlds population due to improved nutrition and a decrease in infectious diseases 
and other causes of death in young individuals, a larger percentage of the worlds 
population is living longer with an increased risk of developing chronic diseases 
such as COPD [29]. Older workers with longer duration of exposure to agents 
recognized in COPD causation may be at greater risk for developing COPD. 
 
The role of gender in the pathogenesis of COPD remains controversial. 
Historically, men smoked more than women, and together with occupational 
exposures exhibited a greater prevalence of COPD. However, evidence has 
shown that the proportion of women who smoke is increasing worldwide [29] and 
the question of whether women, given similar environmental and or occupational 
exposures are at higher risk of developing COPD compared to men remains 
unresolved. 
 
Although occupational exposures are increasingly implicated in the causation of 
COPD, not all individuals similarly exposed are affected. Two studies conducted in 
1978 and 1984 showed that among workers with similar demographic, smoking 
and occupational reports, those with positive metacholine challenge tests 
demonstrated a greater loss of lung function than those with a negative challenge 
test [13]. Atopy and non-specific bronchial hyper responsiveness have been 
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recognized as risk factors for COPD. Furthermore, although there has been a 
suggestion that atopy and non-specific bronchial hyper responsiveness can modify 
the effect of smoking on COPD, current evidence does not  support this theory for 
the effect of silica dust on lung function loss [4].  
 
In summary, studies internationally have indicated that occupational exposures 
may account for 15% of COPD,with a synergistic effect with smoking, and the 
implication of a range of exposures in the causation of COPD. The majority of 
these studies have been undertaken in developed countries with established laws 
and regulations governing occupational exposures, and so the presumption is that 
a greater burden of disease may be prevalent in less developed countries due to 
unregulated or poorly regulated working conditions. As there is a scarcity of 
research into COPD and occupational exposures in developing countries, South 
Africa included, this study intends to determine if similar exposure-response 
associations are valid for occupationally exposed workers in developing countries.  
 
PURPOSE OF THE RESEARCH 
To determine the role of occupational exposures as a risk factor for chronic 
obstructive pulmonary disease (COPD) among physician-diagnosed COPD 
patients attending three hospitals in  Kwazulu-Natal. 
 
SPECIFIC OBJECTIVES 
1. To describe the demographics, lung function and severity of disease in patients 
with a confirmed diagnosis of COPD from three hospitals. 
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2. To describe the occupational exposure history among cases of COPD  and 
controls from three hospitals. 
3. To describe the respiratory symptoms of participants 








110 cases with a physician’s diagnosis of COPD and 102 controls with non-
respiratory related diagnoses were recruited from three public sector hospitals in 
KwaZulu-Natal. All participants completed an interviewer administered 
questionnaire which assessed past medical history, smoking and occupational 
history. Cases provided a copy of a lung function test performed on the day of the 
interview. Analysis was done using STATA version 10. Multivariate logistic models 
were developed to evaluate the effect of occupational exposures on COPD whilst 
controlling for other co-variates. Ethical approval for the study was obtained from 
the relevant institutions and voluntary informed consent was sought from each 
participant. 
 
STUDY DESIGN AND STUDY POPULATION 
This was a hospital based case-control epidemiological study. Participants were 
recruited from  three public sector respiratory clinics in KwaZulu-Natal between 
December 2008 and May 2009. These clinics are located at Inkosi Albert Luthuli 
Central Hospital, Grey’s Hospital and RK Khan Hospital. Although these hospitals 
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offer three different levels of care, the respiratory clinics are specialist level clinics. 
The diagnosis of COPD by a respiratory physician formed the basis of the case 
definition in this study. Cases of COPD were known and newly diagnosed  cases 
(n=110), as diagnosed by a respiratory physician and supported  by spirometry. All 
outpatients with a confirmed diagnosis of COPD attending the respiratory clinics 
were eligible for inclusion in the study.  These patients are referred to these 
specialist centers either for improved control of symptoms, correction of inhaler 
technique, or confirmation of diagnosis.  
 
Controls (n=102) were recruited from non-respiratory chronic illness clinics, 
namely cardiovascular, diabetic and renal clinics (Table 6) at the same hospitals. 
The diagnoses among the controls included diabetes, ischaemic heart disease, 
hypertension and renal disease. Potential controls were excluded if they had ever 
had a diagnosis of a respiratory or COPD related disease or if they had used any 
COPD respiratory medication including inhalers within the past 12 months. 
Controls and cases were group frequency matched for sex and age.  
COLLECTION OF INTERVIEW DATA  
Each participant (case and control) was subject to an interviewer administered 
questionnaire The questionnaire (Appendix D) was developed using a previously 
validated questionnaire (extensively field validated in other South African settings) 
[68] based on the ATS, National Institute of Occupational Health and Safety 
(NIOSH), and ECRHS . Questionnaires were prepared in two official South African 
languages namely English and isiZulu and the latter was verified by back 
translation into English. The questionnaire was administered to the participants in 
the language of their choice by trained interviewers during the participants’ routine 
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follow-up visits to the respiratory clinics. The questionnaire contained 
predominantly closed questions with a few open ended questions. The 
questionnaire included questions on demographics, medical and occupational 
history, respiratory symptoms, smoking habits, family history, as well as domestic 
and environmental exposures. Tobacco smoking questions included age of 
starting and stopping smoking, duration and intensity of smoking. 
 
COLLECTION OF EXPOSURE DATA 
Several questions concerning occupation were incorporated in the 
questionnaire. These included: employment status, current and all previous jobs 
held (job description, industry, duration of employment), and self-reported 
occupational exposures. Information on all self reported exposures was collected 
for each participant for all jobs (up to 10) performed up until retirement or 
retrenchment. Every exposure was given a specific numerical code and up to 5 
exposures were entered for each job performed by the participant. The total 
number of years with exposure to jobs involving exposure to dust and or  
chemicals, gas or fumes was summed up for each participant. If they were 
employed in the same industry but in different occupational categories, they were 
treated as different jobs.  
 
In addition, questions relating to employment in industries with exposures 
associated with the development of COPD, including duration of exposure, were 
also included to ensure that as complete an exposure history as possible was 
collected. These included questions on whether or not they had ever worked in a 
foundry, with asbestos, in pottery, with diesel or diesel fumes, in a flax, cotton or 
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hemp mill, in tunnelling, in drilling, in sandblasting, in a quarry, and with any other 
dusty occupations or with chemicals. Gases and fumes were also asked about. 
 
SPIROMETRY 
A copy of an acceptable and reproducible lung function test (LFT) was obtained for 
all but two of the participants with a physician confirmed diagnosis of COPD. The 
lung function tests were performed on the day of the interview. The tests were 
performed  by each of the three hospitals own inhouse respiratory technician. All 
the technicians followed the procedures stipulated in the South African Thoracic 
Society and the ATS  guidelines [69, 70]. LFTs were assessed for acceptability 
and reproducibility using the ATS criteria and those LFTs that met the criteria were 
accepted. Acceptability criteria that were considered included a “crisp” 
unhesitating start, peak expiratory flow of the flow-volume curve achieved within 
the first 25% of the volume expired from maximum inspiration, a continuous 
smooth exhalation, and a complete exhalation [69]. The measurements that were 
considered for the purposes of this study were forced expiratory volume in one 
second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio. 
 
Failure to meet reproducibility criteria was not  a basis for exclusion of the subject 
from the data analysis, as prior studies indicate that this can introduce a 
substantial selection bias. Those with chronic disease are less likely to provide 
repeatable results and “test failure” may be an indication of ill-health [71]. Those 
LFTs not meeting the ATS criteria were reviewed in terms of the latter statement 




The lung function test equipment used was volume calibrated every four hours on 
the days of testing with a 3 litre calibrated syringe. Systems were checked for 
leaks as well. A minimum of 3 acceptable forced vital capacity (FVC) manoeuvres 
were performed up to a maximum of 8 if reproducibility criteria were not met. The 
largest FVC and FEV1 obtained from any acceptable curves were used for 
recording purposes. Reproducibility criteria were a less than 5% variation or 0.1L 
difference of the largest FVC and FEV1 and the next largest of these parameters 
among all acceptable curves. Internal standardisation of spirometry was done 
using regression equations for height, age and cumulative exposure. As there is  
substantial variation in lung function values between populations and the absence 
of an appropriate set of reference values for the population under study, external 
standardisation was only done to determine levels of disability for the purposes of 
identifying those workers who were eligible for workers’ compensation [72]. 
Reference values of the European Community for Coal and Steel [73] were used 
for the latter purpose. The Global Initiative for Obstructive Lung Disease (GOLD) 
classification system was used to classify severity of lung function impairment. 
 
STATISTICAL ANALYSIS 
Data was captured on an excel spreadsheet and analysed using STATA version 
10. Data was double entered to ensure accuracy. The database was structured 
such that ranges were examined for impermissable values, logic checks for 





The data analysis examined the relationship between COPD and occupational 
exposures. The main health outcome variable (dichotomous) for this study was the 
presence or absence of COPD. Other symptom-related outcome variables 
included respiratory symptoms of shortness of breath, sputum production, cough 
and wheeze (all dichotomous variables). Exposure variables assessed were 
exposure to two composite variables (dust and chemicals, gas or fumes (CGF)), 
duration of exposure to each, as well as specific exposures such as to asbestos, 
diesel and diesel fumes, sandblasting and tunnelling. Duration of exposure for 
asbestos, sanding etcetera was included in the composite variable “dust”.  
Participants were categorised as having exposure “yes” for the variable CGF if 
they reported having exposure to one or more of the three exposures. The 
potential confounding risk factors for COPD included age, sex, smoking status, 
and history of previous personal respiratory illness such as tuberculosis and 
asthma. Univariate analyses described the characteristics of the study population 
as well as the frequencies of independent and dependant variables. Bivariate 
analyses described the crude associations between the variables of interest. For 
bivariate analysis we used the independent samples t test to determine the 
significance of differences between the cases and controls with respect to 
continuous variables (age, years of exposure to dust, years of exposure to 
chemicals, gas or fumes) and the chi-square test for categorical variables sex, 
smoking history, history of tuberculosis, dust exposure, chemical, gas or fume 
exposure, respiratory symptoms.   
 
Linear and logistic regression analyses using 3 models were performed. Logistic 
regression analysis was used to describe the association between COPD and 
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occupational exposure to dust and chemicals, while controlling for age (analysed 
in 10 year age increments), sex, past history of tuberculosis and smoking history.  
Three dummy variables for smoking (never, ex and current smoking) were created 
to evaluate the effect of each level of smoking on risk of COPD. For the 
multivariate logistic regression models, odds ratios and 95% confidence intervals 
(CI) are presented. For FEV1 outcome, the linear regression models were 
adjusted for age, height, smoking history and past history of tuberculosis. The 




Ethical approval for the study was obtained from the Biomedical Research Ethics 
Committee of the University of Kwa-Zulu Natal (Reference Number: BF 123/08) 
(Appendix A). Institutional permission was obtained from each of the three 
participating hospitals as well as from the Health Research and Knowledge 
Management sub-component department of the Provincial Department of Health 
(Appendix B). Informed consent was obtained from each study participant for 
questionnaire administration and from each case for a copy of their lung function 
test. Hard copies of the questionnaires were kept in a locked filing cabinet in the 
Department of Occupational and Environmental Health. The electronic copy was 
stored on the laptop of the investigator to which only the primary investigator and 
co-investigator had access. In the event of publication, data will be presented as 
grouped data without any individual identifiers. Feedback on study findings will be 
provided to the Department of Health, the relevant hospital managers, as well as 
to the individual participants on completion of the study.  In the event that any 
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participant is identified as being eligible for compensation, necessary steps will be 






DEMOGRAPHIC CHARACTERISTICS AND SMOKING 
112 patients with COPD assessed at the clinics during the study period were 
invited to participate. With the exception of two cases, (one male and one female) 
all agreed to participate. Of those patients (103) invited to join the study as a 
control, one declined to participate citing unwillingness to lose his position in the 
consultation booking system.  
 
The sample comprised a total of 110 cases with a physician-confirmed diagnosis 
of COPD and 102 controls (Table 4). In total, there were 25 (11.8%) females and 
187 (88.2%) males. In both the groups, males constituted just fewer than 90% of 
participants. There was no significant difference between cases and controls with 
respect to sex distribution or age. The mean age among the cases was 61.5 years 
(sd: 8.9) and among the controls was 62.1 years (sd: 8.9). Cigarette smoking 
across the various smoking categories differed significantly (p=0.000) between 
cases and controls (93% vs 74% ever smokers) (Tables 4 and 5) 
 
Controls reported hypertension, cardiac disease as well as other chronic illnesses 
(Table 6). A large proportion of the control patients reported a combination of 
medical conditions. Forty three (42%) of the controls were diagnosed with 
hypertension as well as cardiac disease; 42 (41%) with hypertension and other 
chronic illness, and 25 (24.5%) with both cardiac and other chronic illness (data 
not shown). Among the cases, 47 (42.7%), 26 (23.6%) and 16 (14.5%) reported 
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hypertension, cardiac disease, and both hypertension and cardiac disease 
respectively. 
 





Age (mean) (range) 
Male 61.4 (41-86)       62.6 (40-87) 
Female 62.5 (43-80)      58.5 (41-77) 
Sex, n (%) 
Male  96 (87.3) 91 (89.2) 
Female 14 (12.7) 11 (10.8) 
Smoking status, n (%) 
Non-smokers  8 (7.3) 27 (26.5)* 
Ex-smokers  79 (71.8) 47 (46.0)* 
Current smokers 23 (20.9) 28 (27.5) 
*p<0.01  
 
Table 5. Smoking history by sex within each group of smokers 
 Never smokers, n 
(%) 
Ex-smokers, n (%) Current smokers, n 
(%) 
 Cases controls Cases Controls Cases Controls 
Males** 5 (5.0) 19 (21.0) 70 (73.0) 45 (49.0) 21 (22.0) 27 (30.0)











Table 6. Reported medical conditions of controls 
Diagnosis Number (%) 
Hypertension 74 (72.5) 
Cardiac disease 58 (56.9) 
Other chronic illness (diabetes, renal) 54 (52.9) 
 
 
OCCUPATIONAL HISTORY AND EXPOSURES 
The 110 cases self-reported a total of 340 job descriptions among themselves, 
averaging 3 different jobs over their working lifetime (Table 7). Controls reported 
221 job descriptions, an average of 2 jobs per control.  A larger proportion of the 
controls reported employment in administrative (21.3% vs 12.0%), managerial 
(7.7% vs 2.6%) and quality control (5.4% vs 0.3%) positions compared to cases. 
With the exception of employment in the construction and shoe manufacturing 
industries, reported percentage of employment of cases and controls in other 
industries was similar (Table 8). Job descriptions and employing industries that 














Table 7. Frequent job descriptions reported by cases and controls 





Administrative 41 (12.0) 47 (21.3) 
Machinist (textile and shoe)     30 (8.8) 13 (5.9) 
Builder 27 (8.0) 6 (2.7) 
Driver 19 (5.6) 22 (10.0) 
Fitter and turner 19 (5.6) 4 (1.8) 
Operator 18 (5.3) 17 (7.7) 
Painter 16 (4.7) 0 
Supervisor 14 (4.1) 8 (3.6) 
Welder 12 (3.5) 2 (1.0) 
Maintenance 10 (3.0) 0 
Manager 9 (2.6) 17 (7.7) 
Mechanic 6 (1.8) 5 (2.2) 
QC 1 (0.3) 12 (5.4) 






















Table 8. Cases and controls employment by industry 





Construction 35 (10.3) 7 (3.2) 
Shoe manufacturing  34 (10.0) 11 (4.9) 
Food industry 31 (9.1) 21 (9.5) 
Textile and clothing        30 (8.8) 33 (14.9) 
Transportation 23 (6.8) 14 (6.3) 
Retail 18 (5.3) 17 (7.7) 
Motor industry 15 (4.4) 14 (6.3) 
Paper/ packaging/printing 13 (3.8) 12 (5.4) 
Engineering 13 (3.8) 5 (2.2) 
Furniture manufacturing 12 (3.5) 8 (3.6) 
Metal and steel industry 12 (3.5) 3 (1.4) 
Petroleum industry 9 (2.6) 2 (1.0) 
Shipping 8 (2.4) 4 (1.8) 
Health care 7 (2.0) 7 (3.2) 
Mining 6 (1.8) 0 (0.0) 
Chemical 5 (1.5) 0 (0.0) 
Plastic 4 (1.2) 5 (2.2) 
Finance 3 (0.8) 5 (2.2) 
  
 
Self-reported occupational exposures were more common among the cases than 
controls.  Among the cases, 72% reported exposure to dust, 74.5% reported 
exposure to CGF and 76.9% reported exposure to dust as well as CGF. The 
proportion of controls exposed to dust, to CGF and to both dust, and CGF was 
28%, 25.5% and 23.1% respectively. The proportion of cases with occupational 
exposures was significantly higher when compared to controls (p< 0.001) (Table 
9). Stratification by sex revealed that a significantly higher proportion of both male 
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and female cases reported  occupational exposures compared to controls (Table 
10). 
 
Employment status (“ever being employed”) did not differ significantly between 
cases and controls. However, cases were more likely to be currently unemployed 
due to poor health than controls (54% vs.18%, p= 0.02) (not shown).   
Table 9. Occupational exposure profile of cases and controls 




Dust 80 (72.0) 31 (28.0)*
Chemicals, gas or fumes 76 (74.5) 26 (25.5)*
Dust and chemicals, gas or 
Fumes 
60 (76.9) 18 (23.1)*
*p<0.001; chi² test   
 
Table 10. Occupational exposure by sex  
 Cases, n (%) Controls, n 
(%)
Female, n, (%) 
Dust  8 (57.1) 0 (0)**
Chemicals, gas or fumes 8 (57.1) 1 (9.1)*
Dust and chemicals, gas  
or fumes 
4 (28.8) 0 (0)
Males, n, (%) 
Dust 72 (75) 31 (34.1)***
Chemicals, gas or fumes 68 (70.8) 25 (27.5)***
Dust and chemicals, gas  
or fumes 
56 (58.3) 18 (19.8)***




As indicated in Table 11, duration of exposure to self reported occupational 
exposures differed significantly between cases and controls (p<0.001). Among the 
cases the mean number of years for exposure to dust and CGF was 15.7 years 
and 14.0 years respectively. The corresponding mean duration of exposure for 
controls was approximately 3-4 times lower than those for the cases. 
 

























RESPIRATORY SYMPTOMS AND DISEASE DIAGNOSIS REPORTED BY 
PARTICIPANTS 
As expected, respiratory symptoms of cough, phlegm, breathlessness, and 
wheeze were reported by 66%, 69%, 85% and 89% of the cases respectively. Of 
note however, is the reporting of breathlessness by approximately 53% of the 
controls, with wheeze reported by 22%.  
 
Disease diagnoses of asthma (68%) and pneumonia (35%) were the most 
common respiratory diseases reported by cases. A history of tuberculosis was 
reported by 15.5% of the cases and 2.0% of controls. Fewer than 10% of controls 
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reported the presence of any other respiratory diseases (data not shown). Of the 
110 cases, 59 (54%), reported ever experiencing symptoms of tight chest or 
wheeze at work compared to 11(11%) of the controls. In addition, 39 (35.5%) of 
those with COPD left work because of respiratory complaints compared with 4 
(3.9%) of the controls (p<0.001). 
 
MULTIVARIABLE LOGISTIC REGRESSION ANALYSES  
The association between self-reported exposure to dust and chemical, gas or 
fumes and COPD is summarized in Table 12.  
 
After adjustment for co-variates including smoking, exposure to dust, and 
exposure to CGF was associated with an increased odds of developing  COPD. 
The odds ratio for exposure to dust was 7.9 (95% CI 3.9-15.7; p<0.001). For 
exposure to chemicals, gas or fumes, the odds ratio was 6.4 (95% CI 3.2-12.8; 
p<0.001). For participants exposed to dusts as well as chemicals, gas or fumes, 
the odds ratio was also significantly elevated at 5.8 (95% CI 2.9-11.7; p<0.001). 
 
A history of tuberculosis was strongly associated with an increased odds of being 
a case especially in the two models incorporating dust exposure (p< 0.05 for both). 
Although tuberculosis was associated with COPD in the 2nd model, the association 
was not significant (p=0.13). Smoking history showed a strong association with 
COPD. The odds ratio for ex smokers were markedly higher than for current 
smokers and were significant across all three models. Current smoking was 




Male sex was protective against having COPD and the association was significant 
in the models that included exposure to dust. The OR for COPD for 10 year 
increments in age was not significant in any exposure group. 
 
 
Table 12. Adjusted odds ratios for COPD   
 Model 1# Model 2## Model 3### 
    









1.01 (0.98-1.06   ) 1.02 (0.98-1.06   )  1.02 (0.98-1.05 ) 
Sex^ 
 
0.2 (0.07-0.7)* 0.3 (0.1-1.0) 0.3 (0.1-0.8)* 
Tuberculosis 
 
8.1 (1.6-40.4)* 3.5 (0.7-16.9) 5.7 (1.2-27.4)* 
Ex-smoker 
 
7.9 (2.8-22.2)** 5.4 (2.1-16.5)* 6.4 (2.3-17.7)** 
Current smoker 
 
4.6 (1.4-14.3)* 2.7 (0.9-8.4) 3.5 (1.1-10.9) * 
Dust exposure 
 
7.9 (3.9-15.7)** ----- ----- 
Chemical, gas or fume 
exposure 
----- 6.4 (3.2-12.8)** ----- 
Dust and chemical, gas 
or fume exposure 
 
----- ----- 5.8 (2.9-11.7)** 
 
* p <0.05 
** p <0.001 
OR= odds ratio 
CI= confidence interval 
*** based on 10 year increments in age 
# Model 1: Dust exposed 
## Model 2: Chemical, gas or fume exposed 
### Model 3: Dust and chemical, gas or fume exposed  





LUNG FUNCTION AMONG CASES 
Acceptable and reproducible lung function test results were available for 98% of 
cases (no lung function tests were obtained for any of the controls, and hence no 
comparative analysis has been done). Approximately 97% of subjects with COPD 
had GOLD stage II or greater disease severity with just about 70% having stage III 
or higher disease severity (Table 13).  
 






GOLD Stage n (%) 
GOLD Stage II 30 (27.8)
GOLD Stage III 44 (40.7)
GOLD State IV 31 (28.7)
 
 
Table 14 presents the results of the unadjusted lung function parameters. The 
analyses of the effect of self-reported dust and chemical, gas or fume exposure on 
FEV1 is summarised in Table 15. Models adjusting for age, sex, height, smoking 
status and history of tuberculosis did not indicate any significant association 










Table 14. Unadjusted lung function parameters 
 


















Table 15. Adjusted effect of explanatory variables on FEV1 from different 
linear regression models 
Co-variates Model 1#  Model 2##  
 
Model 3### 













 (-0.01 - 0.01) 
0.0  
(-0.01 - 0.01) 
0.0 





(-0.4 - 0.1) 
-0.2  
(-0.4 - 0.1) 
-0.8  





(0.0 - 0.03)* 
0.02  
(0.0 - 0.03)* 
0.02  





(-0.8 - 0.03)* 
-0.4 
 (-0.8 - -0.01)* 
-0.4 





(-0.8 - 0.05) 
-0.3  
(-0.7 - 0.1) 
-0.3 





(-0.1 - 0.5) 
0.2  
(-0.2 - 0.5) 
0.2  





(-0.3 - 0.2) 
- - 
Chemical, gas or fume 
exposure 
- 0.02  
(-0.2 - 0.2) 
- 
 
Dust and chemical, 
gas or fume exposure 
 
- - 0.03




# Model 1: Dust exposed 
## Model 2: Chemical, gas or fume exposed 








This, the first hospital based case-control study of COPD undertaken in 
South Africa, indicated that occupational exposures are associated with a 
substantially increased odds for the development of COPD. For those 
exposed to occupational dusts there was an almost 8 fold increased odds, 
while those exposed to chemicals, gases or fumes had a 6.4 fold increased 
odds for having COPD. The exposure-related odds  estimates (OR 7.9; 6.4 
for dust and CGF exposure respectively) were higher than that for current 
smokers (OR 4.6; 2.7), and similar to that of ex-smokers (OR 7.9; 5.4). 
 
The findings of this study are consistent with those described in several 
other studies internationally [4, 7, 11,13-16, 27,41,64]. Occupational 
exposures, namely organic and inorganic dusts, as well as vapours, gases 
and fumes have been identified as important predictors of COPD in 
numerous epidemiological studies. In two recently published case control 
studies, exposure to vapours, gases, dust and fumes  was associated with 
a two-fold increase in the risk of COPD [41, 64]. The odd ratios described in 
other studies range from 1.6 through to 2.7 [16,27,7]. In this study however, 
we observed considerably higher odds estimates for COPD.  There are 
several possible explanations for this finding. A substantial proportion of 
cases in this study reported employment in the textile and shoe 
manufacturing industries. Previous studies reporting an increased risk of 
COPD were conducted mainly in the construction, agricultural, food 
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processing, mining, quarrying, and wood industries as well as foundries [3, 
15, 17, 18, 30, 43, 53]. Mastrangelo et al [39] observed a limited distribution 
of participants within the textile and shoe industries. It is possible that a 
greater proportion of cases in this study, employed in the textile and shoe 
manufacturing industries were occupationally exposed to dust and to 
chemicals, gas or fumes. An additional  hypothesis is that participants in 
this study had higher levels of exposure to risk factors. However, we have 
no reason to believe that the problem is greater in this industry without 
gaining more objective data.  
 
From a public health point of view, the current study provides several 
important findings. A past history of tuberculosis was strongly and 
significantly associated with the presence of COPD – odds ratios ranging 
from 3.5 to 8.1, depending on the exposure variable. A similar finding was 
demonstrated in a South African population based study in 2004 [7] in 
which the strongest predictor of chronic bronchitis was a past history of 
tuberculosis (males, OR  4.9, 95% CI 2.6-9.2; females, OR 6.6, 95% CI 3.7-
11.9). In a more recent population-based study, tuberculosis was also 
associated with airways obstruction, with the authors reporting an adjusted 
OR of 2.33 (95% CI 1.5-3.6) [67]. This has important implications for 
tuberculosis detection and cure rates as single as well as repeated 
episodes of tuberculosis have been associated with chronic airflow 
limitation [60]. Although not explicity investigated in this study, it is possible 
that lung function loss from tuberculosis could be modified by occupational 
exposures in the workplace. It is thus in the interests of public health to 
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ensure that the tuberculosis control programme meets its targets for 
detection and cure rates, to assist in diminishing the burden of COPD in 
addition to the obvious objectives of reduced mortality and spread of the 
disease. However, more if not just as important, would be the development 
of  TB programmes in dusty workplaces which would identify workers with 
TB early in the course of disease. Early identification and appropriate 
treatment could reduce the potential for developing COPD. 
 
The positive association between smoking and COPD in our study was 
similar to that for  occupational exposures among ex-smokers, and is very 
similar to the risk reported by other researchers (61).The similarity in risk 
estimates for  smoking and occupational exposures provides a considerable 
argument for the focusing of similar attention and resources to the control of 
workplace exposures as to anti-smoking campaigns nationally and 
internationally. 
 
Given that the estimated worldwide population attributable fraction (PAF) for 
COPD due to occupational exposures is 15-20% [2], better characterisation 
of specific occupational exposures has important public health policy 
implications. The findings from this study suggest that persons with known 
occupational exposures to respiratory irritants should be monitored to 
detect the onset of respiratory ill-health and that preventive strategies 
should reduce exposure to these agents in the workplace. A study [16] 
among 5724 participants with early COPD investigating the effect of 
occupational exposures on decline of lung function in early COPD,  
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provided clear evidence for secondary screening and secondary prevention 
in persons with early COPD exposed to fumes. Individuals with early COPD 
should avoid, or at least limit ongoing occupational fume exposures, as 
evidence indicates that regular exposure to fume after COPD onset has an 
adverse impact on lung function [16]. In particular, because individuals with 
COPD already have existing impaired lung function, and in comparison to 
normal people, have an accelerated loss of lung function capacity, any 
further functional loss due to workplace exposures may be very significant. 
This view is supported by the 1985 review of MR Becklake which identified 
certain exposures for which there is evidence of a causal relationship in the 
development of chronic airflow limitation [3]  
 
Cases and controls exhibited large differences in self reported symptoms 
and disease, with the reported prevalence of breathlessness and wheeze 
surprisingly high in the controls (53% and 22%). A possible explanation lies 
in the source clinics from which the controls were recruited, All of the 
controls were recruited from either the cardiac, hypertensive, diabetic or 
renal clinics with the majority reporting a hypertensive or other cardiac 
related diagnosis and this could account for the increased prevalence of the 
respiratory symptoms. An additional interesting finding is the large number 
of cases (68%) who reported having asthma. In the authors opinion, it is 
likely that individuals who develop wheeze and breathlessness assume that 





Although this study has found strong associations between occupational 
exposures and risk of COPD, several limitations were identified that may 
have biased the estimate away from the null. Cases (both prevalent and 
incident) were identified and selected from the specialist respiratory clinics 
of three public sector hospitals and disease status and severity confirmed 
by spirometry. This study found that approximately 70 % of cases had stage 
3 to 4 disease as per the GOLD classification system. Individuals with less 
severe stages of disease were under-represented in the study. A likely 
explanation would be that only patients with moderate to severe disease 
are usually referred to these specialist respiratory clinics while those with 
less severe disease are managed at peripheral hospitals and clinics. 
Furthermore, inclusion of cases from the more severe end of the spectrum 
could have biased the estimate away from the null.  
 
Misclassification of controls as non COPD could have occurred as they 
were not systematically and objectively screened via spirometry to exclude 
obstructive lung disease. For controls, disease misclassification was limited 
by enquiring about and subsequently excluding, those individuals who 
provided an affirmative response to questions relating to ever having had a 
diagnosis of a COPD related disease or ever having used any COPD 
related medication including inhalers within 12 months of the interview. For 
all cases, except two, medical records as well as availability of lung function 
testing enabled verification of reported physician’s diagnosis of COPD. The 
availability of objective measures of lung function allowed the researcher to 
 60 
 
reduce clinical diagnostic error, to validate airway obstruction, as well as to 
ascertain objectively the stage of disease. 
 
As the majority of the participants were currently not employed, self 
reported information on occupational exposures was collected 
retrospectively with the potential for recall bias. Considering the range of 
ages and the fact that just over 60% of our participants were older than 60 
years, many of them would have left their last job many years prior to this 
study. In addition, many of their exposures would have occurred decades 
earlier, making recall difficult. Exposure classification could be affected 
either by differential or non-differential misclassification. Differential 
misclassification could have occurred if COPD cases reported a more 
complete history of employment and exposures than did controls. However, 
the information on occupation was collected twice on the questionnaire and 
in almost all instances; the participants provided similar accounts of 
occupations and exposures. Without objective quantifiable evidence of 
workplace exposures, it is possible that many cases of COPD may have 
overestimated their exposures and this could be biasing the results towards 
an inflated OR. Other objective measures of exposure eg job exposure 
matrices would probably better identify cases that are exposed as opposed 
to self reports of exposure. If cases were more likely to recall their past 
exposures than controls, this is likely to have biased the odds ratio estimate 
away from the null. Furthermore, misclassification of COPD patients as 
controls would have biased the estimate towards the null. An additional 
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limitation is the lack of analysis of the broad classes of occupations and 
industries.  
 
An additional limitation is the bias introduced by the selection of controls 
from specialist clinics. Controls who attend these clinics may be similar to 
cases with regard to regard to health service location; however, they do not 
necessarily represent the general working population with regards to 
exposures, namely smoking and occupational exposures. Controls with 
longstanding diagnoses of eg cardiovascular disease or diabetes may have 
a different smoking pattern than the general population. It is also possible 
that their choice of occupation may have been influenced by their chronic 
illnesses in that they may have selected less exposed occupations. 
 
Due to difficulty in apportioning the relative contributions of different 
exposures to the development of COPD, there may be an adversarial 
approach to compensation of COPD as an occupational disease. No 
guidelines exist to assist in attributing risk among multiple exposures. In 
South Africa, COPD is recognised as a compensable occupational lung 
disease only  among miners with more than 10 years history of exposure. In 
addition, in less developed countries where the prevalence of cigarette 
smoking is typically lower, the relative contribution of exposures other than 
smoking may be more significant [7]. Furthermore, in South Africa, the 
control of occupational exposures suffers from inadequate enforcement of 




The question “should a person with COPD remain in his or her job if it 
involves exposure to gases, dusts or fumes?” begs an answer. Although 
studies [16, 52] have reported that ongoing exposure increased lung 
function impairment removal of individuals from their jobs without suitable 
alternatives for employment can result in severe  consequences. The better 
option would be to protect workers’ health by reducing workplace exposures 
to ensure the health and safety of all employees.  
 
In conclusion, these findings lend further support to the body of evidence 
causally linking occupational exposures to the development of COPD. This 
recognition is important for the public health sector in its attempts to 
address the morbidity and mortality associated with COPD by focussing on 
smoking cessation as well as reduction of causal occupational exposures. 
Control of occupational exposures could have a profound impact on COPD 
by reducing prevalence by at least 15% [2]. Furthermore, renewed efforts to 
improve tuberculosis detection and cure rates, in addition to reducing 
morbidity and spread of disease, will also assist in diminishing the burden of 
COPD. Clinicians involved in the management of patients with COPD, or 
patients employed in jobs with potential for occupational exposure to causal 
agents, need to identify the disease at its early stages and appropriately 
advise reduction of exposures to prevent initiation and or progression of 
COPD. Regulatory agencies and decision makers responsible for 
compensation of occupationally acquired diseases, specifically in the non-
mining sector in South Africa, need to take cognisance of these findings 
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CONSENT TO PARTICIPATE IN A STUDY OF OCCUPATIONAL EXPOSURES 
AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
1. Title of research project 
Occupational Exposures and Chronic Obstructive Pulmonary Disease 
 
2. Introduction 
My name is Dr N Govender and I am from the Department of Occupational 
and Environmental Health at the Nelson R Mandela School of Medicine. I am 
conducting research about a lung disease called Chronic Obstructive Pulmonary 
disease and would like a few minutes of your time to determine if you would be 
interested in being part of the study. I have selected you because you have the 
disease that I am interested in. The number of people with Chronic Obstructive 
Pulmonary Disease is increasing worldwide. As a result there are more patients 
with this disease being seen at health care facilities. We know that cigarette 
smoking is the commonest cause of this disease. However, there is a lot of 
research that shows that hazards to which people are exposed to at work may 
also be causing or contributing to this illness. These hazards/ exposures may 
include certain types of dusts and chemicals that workers inhale and we believe 
that workers exposure to these hazards is increasing and as a result more workers 
are developing COPD. However there is very little information on this in our local 
setting in KwaZulu-Natal. 
 
3. Names of the researchers 
Dr. Rajen Naidoo, 
MB.ChB, PhD 
Department of Occupational and Environmental 
Health, University of KwaZulu-Natal, South Africa 
Telephone: 031-260 4385; Fax: 031-260 4663 
Dr. Nadira Govender, MB. 
ChB, DOH 
Department of Occupational and Environmental 
Health, University of KwaZulu-Natal, South Africa 




4. Purpose of the research 
We wish to ask you to participate in an investigation, called " Occupational 
Exposures And Chronic Obstructive Pulmonary Disease”. The purpose of this 
study is to determine the role of occupational exposures as a risk factor for chronic 
obstructive pulmonary disease. Identifying the possible contributing causes of 
COPD among workers will assist us in identifying the types of work and industries 
that may be responsible for contributing to this increased burden of COPD. This 
will assist in contributing to the development of policy relating to work-related 
COPD. 
 
5. Description of the research project 
If you agree to participate in the study, you will be asked to complete the following 
at one of your clinic visits to this hospital: 
a). Complete a questionnaire. A member of our research team will administer a 
questionnaire to you in one of the following languages of your choice: English or 
isiZulu. Should these not be a language of your choice, please advise the 
interviewer, who will inform the Principal Investigator of the study. You will be 
asked questions about yourself, about your health and any chest symptoms that 
you may have or had in the past, past chest illnesses, your smoking history, 
history of your job including previous jobs and your family history. Based on our 
previous experience in the administering of similar questionnaires, this interview 
will take about 45 minutes to complete. You may be asked to complete the 
questionnaire for a second time. This is a check to determine if the information 
is being collected and entered correctly. The re-interview will take place at your 
next clinic visit and will thus not require a special visit to the clinic. 
 
We will also obtain the following information from your hospital records: 
a). Lung function test: This is a test of how well your lungs work, and you will 
have had this done at one of your visits to this clinic over the last year. Should 
this test not be of appropriate quality, then we will request that another test be 
done at the date of your interview, as part of your normal clinical assessment. 
You will be asked to blow into a machine. The results of this test will tell us 




 Risks and discomforts of the research and measures taken to reduce 
this 
a). From the interview. During the interview, you will be asked personal questions. 
This may cause you to feel uncomfortable. If you are unhappy to answer any 
question, please inform the interviewer. You will not be forced to answer any 
question. 
b). From lung function tests. Should a new lung function test be required, this 
will be done by trained technicians. There are no side effects of this test, but if 
you do suffer from wheezing or asthma, the deep blow that you give into the 
machine may cause your chest to become a little tight for a short while. This 
can always be quickly treated by asthma treatment. You should inform the 
technician and doctor before you do the test, that you do have this problem. 
Should your chest become tight after the test, inform the technician 
immediately, who will inform the doctor to supervise your medication. 
 
6. Expected benefits to you and to others 
You will be given a written copy of all your test results along with an 
interpretation of their meaning. Should any of our results find that you have a 
disease as a result of the work that you do, and should this be compensable 
under the law, then we will refer you to an appropriate centre for further 
assessment and intervention. On completion of the study, a report highlighting 
the main study conclusions will be forwarded to you 
 
7. Costs to you resulting from participation in the study 
The study is offered at no cost to you.  In the event a compensable disease is 
identified and you need to be referred to a specialist unit, we can recommend to 
you who to see.  However, any additional costs of such medical visits or 
treatments will not be the responsibility of the study team. The interviews and 
any other tests that may be necessary will be done during your normal clinic 
visit, while you wait to be assessed by the respiratory consultants. We do not 
anticipate taking up any additional time. However, should unexpected delays 
occur, and you incur additional costs related to the research, this will be 




9. Confidentiality of information collected 
Your name will not appear in any reports on this study. The records of 
questionnaires and other tests will be kept completely confidential and will be 
seen only by members of the study team. 
 
10. Voluntary nature of participation 
Your participation in this project is entirely voluntary. Even after you give your 
consent, you may refuse to participate in or withdraw from the study at any time 
without penalty or loss of benefits. 
 
11. Documentation of the consent 
One copy of this document will be kept together with our research records on 
this study. A second copy will be given to you to keep. 
 
12. Contact person. This study has received ethics approval from the Biomedical 
Research Ethics Committee, University of Kwazulu- Natal. In addition, 
permission to conduct the study has also been received from the medical 
manager of this hospital. If you require further explanation regarding the study 
or if you have any concerns, or answers to further questions about the research, 
your rights, or any problem you may feel is related to the study please contact 
Dr. Nadira Govender at the following telephone numbers: Tel: (031) 
2604471/4676              Cell: 0837171878 
 
If you need to obtain additional information about this study, the contact 
details of the Biomedical Research Ethics Committee, University of Kwazulu- 
Natal are as follows: 
Research Office – tel: (031) 260 4769,  fax: (031) 260 4609;  e-mail: 
BREC@ukzn.ac.za  
 
Consent of the participant 
 I have read [or been informed] of the information given above.  I understand the 
meaning of this information.  Dr./Mr./Ms. ______________ has offered to 
answer any questions I may have concerning the study.  I hereby consent to 





I ___________________________(First name & Surname) consent to 
answering a questionnaire and to having a copy of my lung function test done 
either today or one done in the past 12 months used in this study. 
 
__________________________ _____________________________ 
Printed name of participant   Participant signature 
 
__________________________ ______________________________ 





Consent of the participant 
 I have read [or been informed] of the information given above.  I understand the 
meaning of this information.  Dr./Mr./Ms. ______________ has offered to 
answer any questions I may have concerning the study.  I hereby consent to 
participate in the study.   
 
I ___________________________(First name & Surname) consent to 
answering a questionnaire and to having a copy of my lung function test done 
either today or one done in the past 12 months used in this study. 
 
__________________________ _____________________________ 
Printed name of participant   Participant signature 
 
__________________________ ______________________________ 









QUESTIONNAIRE: Occupational exposures and Chronic 
Obstructive Pulmonary Disease  
 
 
STUDY ID   __________                          DATE: ___/___/___ 
 












CODE  ________ 
 
CITY ____________________   PROVINCE  ____________________ 
 
2. PHONE NUMBER: (_____) ______________ 
 
3. IDENTITY NUMBER: __________________ 
 
4. BIRTHDATE: ___/___/___                                      
 
5. AGE LAST BIRTHDAY            ___________________ (dd/mm/yy)  
 
6. SEX      
M F 
7. MARITAL STATUS: 
1.  MARRIED  __ 
2.  WIDOWED  __ 
3.  DIVORCED  __ 
4.  SEPARATED  __ 











QUESTIONNAIRE: Occupational exposures and Chronic 
Obstructive Pulmonary Disease  
 
 
STUDY ID   __________                          DATE: ___/___/___ 
 






B. SYMPTOMS  
I am going to ask you some questions, mainly about your chest.  I would like you 
to answer "YES" or "NO" whenever possible. 
 
* for night shift workers 
 
8.  COUGH 
 







9.  Do you usually cough first thing in the morning (on getting up*)  






If YES to 8 or 9: 
 







b. Do you cough like this on most days (or nights*) for as much  








c. For how many years have you had this cough?           ___________ 




10.   Do you usually bring up any phlegm/sputum/mucus from your chest first         






11.  Do you usually bring up any phlegm/sputum/mucus from your chest  






IF YES TO 10 OR 11: 
 
a. Do you bring up phlegm like this on most days          







b. Do you usually bring up phlegm at all on getting up or  






c. For how many years have you had trouble with phlegm? _________ 
years 
           
 
 
EISODES OF COUGH AND PHLEGM 
 
12.   Have you had periods or episodes of (increased**) cough and  








13.  Are you troubled by shortness of breath when hurrying on  







14.  Do you get short of breath walking with other people of your  






15. Do you have to stop for breath when walking at your own pace  





16.  Are you too breathless to leave the house or breathless  















IF YES TO 17: 

































IF YES TO 18: 
a. How old were you when you had your first such attack? _______ 
Age in years 
 
 





















IF YES TO 19: 





b. At what age did you first have it?                ______ 
Age in years 
 
 





IF YES TO 20: 





b. At what age did it start?                         ______ 











IF YES TO 21: 




















IF YES TO 22: 


















23. Have you ever had asthma?    





IF YES TO 23: 
a. Do you still have it?          
                    
 
b. Was it confirmed by a doctor?  












c. At what age did it start?                                           ______ Age in years 
 










IF YES TO 24: 






b. Was it confirmed by a doctor?  







c. When did this happen?                                                    ________ Year 
 
 
d. How long did you receive treatment for this                           ___months 
 






f. When did this happen?                                                      _______ Year  
 
 










IF YES,  








26.  Have you ever had: 
 
a. Any other chest illnesses as mentioned by a doctor?     





If yes, please specify ____________________________________________ 
 
 





If yes, please specify ____________________________________________ 
 
 


















28.  Have you had any treatment for high blood pressure (hypertension)  






29.  Have you used any medication to help your breathing at any time  












30. What medications do you use regularly for your lung disease? 
















C: OCCUPATIONAL HISTORY 
 
I would now like to ask you some questions on the types of jobs you have done. 
 
 
READ ALL OPTIONS AND TICK ONE BOX ONLY 
     




Self employed 2 
Unemployed, looking for work 3 
Not working because of poor health 4 
Full time house person 5 





31b.  Please specify response for “Other” 
 _____________________________  
 
32.   If you had more than one job in the same company, or if you were doing more than one job at the same time, we 





What was the 








do, or what 
services did it 
provide? 
INDUSTRY 
For each of these job 
titles, could you list 
the different types of 
substances that you 
were exposed to? 
EXPOSURES 
In what month 
and year did 
you start 
working in this 
specific job 
title? 
In what month 
and year did 
you stop 








     Month Year Month Year  
1  
 
        
2  
 
        
3  
 
        
4  
 
        
5  
 
        
6  
 
        
7          
8          
9          




33.  Do you have any records in your possession or at home that could verify the 






            
IF YES, 







     
 









35. If yes, please tick against the appropriate job number (job number to 
correspond with Q 32) 
 






























37.  If yes, please tick against the appropriate job number (job number to 
correspond with Q 32) 
 
















Record on lines the number of years in which the subject has worked in 
any of the below listed industries. 
 
Have you ever worked: 
 





 No. years ….. 














 No. years……  





 No. years……  






 No. years……  





 No. years……  





 No. years……  





 No. years……  






 No. years……  
 





   
 48a.   Specify ____________________ No. years……  
 
 













        
50.  Specify job/industry: _________________________ Total years worked __ 
 
   




52.  Have you been involved in an accident at home, work or elsewhere that 
exposed you to high levels of vapours, gas, dust or fumes?       







IF YES,  
 
53.  Did you experience respiratory symptoms immediately following this 
exposure?   






IF YES  
 







I am now going to ask you some questions about your smoking habits, if any. 
 
54.  Have you ever smoked for as long as a year? 
(Yes means at least 20 packs of cigarettes or 350gm of tobacco in a lifetime, or 




























57.  How much do you now smoke on average? 
 
 Number 
No of cigarettes per day   
No of cigars per week   













If YES: Go to Q 60 
 


















61.  On average, of the entire time you smoked, before you stopped or cut down, 
how much did you smoke? 
 
 Number 
No of cigarettes per day   
No of cigars per week   





E: FAMILY HISTORY 
 
I am now going to ask you some questions about your family 
 
62.  Were either of your natural parents ever told by a doctor that they had a 
chronic lung condition such as: 
   
 
  FATHER MOTHER 














 1 Chronic Bronchitis       
 2 Emphysema       
 3  Asthma       
 4  Lung Cancer       
 5  Other Chest 
conditions 
      
 
62a.   If OTHER, please specify: (FATHER): ____________  
                                                     






I am now going to ask you some questions about your home environment 
 
63.   How many years have you lived in your current house?   --------------- yrs 
 
 






1 central heating 
 
  
2 ducted air heating (forced air heating) 
 
  







65. Which of the following appliances do you or did you mostly use for heating or 
for hot water? 
 
TICK ONE BOX ONLY 
 
  
 open coal, coke or wood fire                                                     1 
 open gas fire 2 
 electric heater 3 
 paraffin heater 4 
 gas-fired boiler 5 
 oil-fired boiler 6 
 portable gas heater 7 











66. What kind of stove do you/ did you mostly use for cooking? 
 
 TICK ONE BOX ONLY 
 
 coal, coke or wood (solid fuel) 
 
1 












 gas (gas from bottles or other non-mains source)6 
 
6 




67.  What type of stove do you/ did you mostly use in your house? 
 
TICK ONE BOX ONLY  









68.   How often do cars pass your house?  
 














69. How often do heavy vehicles (e.g. trucks/buses) pass your house?  
 




















Thank you for your time for these questions.  
 
We may need to contact you again to obtain additional information. Please give 
me the name, address and telephone number of two relatives or friends who 
would know where you could be reached in case we have difficulty in contacting 
you. 
 
Name of first contact person: 
_____________________________________________________ 
 
Telephone number of first contact person:       __________________ 
 
Relationship of contact person to you: ______________________________ 
 
Name of second contact person: 
_____________________________________________________ 
 
Telephone number of second contact person:       __________________ 
 
Relationship of contact person to you: ______________________________ 
 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE! 
 
END: Thank you for helping us! 
 
Interview completed at:    Time: _ _:_ _ am / pm 
 
